stockrow
Friday 6 November 2026
Export PAVM’s income statement to Excel — free account
PAVmed Inc.
PAVM Healthcare Medical Devices
PAVmed Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71,000.00, down 97.6% from fiscal 2024.
- Revenue
- +450.0%
- EPS
- +96.1%
- Free cash flow
- −125.6%
Quarter to June 2026, against a year earlier
1.57
0.02
+1.29%
Follow PAVM
Alert me
PAVmed Inc. (PAVM) P/E ratio
PAVmed Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 2.3× (January 2026) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 1.3× | 446.94% |
| FY2024 | 0.2× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 1.3× | 5.81% |
| Sep 2025 | 1.2× | 1,296.34% |
| 15 more quarters | Free account |
Against its own ten years
Low 0.0×
High 2.3×
Ten-year median
0.0×
Current reading's percentile
86
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BTCY Biotricity Inc. compare | n/m |
| MODD Modular Medical, Inc. compare | n/m |
| PAVM PAVmed Inc. | n/m |
| SINT SINTX TECHNOLOGIES, INC. compare | n/m |
| PETV PetVivo Holdings, Inc. compare | n/m |
| HSCS HeartSciences Inc. compare | n/m |
| RBOT Vicarious Surgical Inc. compare | n/m |
| IRIX IRIDEX Corporation compare | n/m |
| ITOC iTonic Holdings Ltd. compare | — |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)